{
    "clinical_study": {
        "@rank": "146161", 
        "arm_group": [
            {
                "arm_group_label": "Low dose", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "High dose", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "This trial is conducted in Europe. The aim of the trial is to evaluate growth response of\n      two somatropin dose regimens in girls with Turner Syndrome."
        }, 
        "brief_title": "Growth Response in Girls With Turner Syndrome", 
        "completion_date": {
            "#text": "May 2003", 
            "@type": "Actual"
        }, 
        "condition": [
            "Genetic Disorder", 
            "Turner Syndrome"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Genetic Diseases, Inborn", 
                "Turner Syndrome", 
                "Gonadal Dysgenesis", 
                "Primary Ovarian Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Turner syndrome\n\n          -  If age below 3 years, either body height below - 1 SD (standard deviation) with\n             average growth velocity according to chronological age or body height below 0 SD with\n             growth velocity below -1 SD according to chronological age\n\n          -  If age above 3 years, body height below - 1 SD with average growth velocity according\n             to chronological age\n\n          -  Measured parental height available\n\n          -  Written informed consent"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "31", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01734486", 
            "org_study_id": "GHTUR/F/3"
        }, 
        "intervention": [
            {
                "arm_group_label": "Low dose", 
                "description": "0.9 UI/kg/week. Subcutaneous injection for 3 years", 
                "intervention_name": "somatropin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "High dose", 
                "description": "1.8 UI/kg/week. Subcutaneous injection for 3 years", 
                "intervention_name": "somatropin", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "November 22, 2012", 
        "link": {
            "description": "Clinical Trials at Novo Nordisk", 
            "url": "http://novonordisk-trials.com"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "TOULOUSE cedex", 
                    "country": "France", 
                    "zip": "31059"
                }
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Growth Response in Girls With Turner Syndrome During a Three-year GH Treatment Comparing Two Dose Regimens. Identification of Predictive Factors of Growth Response", 
        "overall_official": {
            "affiliation": "Novo Nordisk Pharmaceutique SAS", 
            "last_name": "Bruno Baron", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2003", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Height gain, SDS (Standard Deviation Score)", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Height gain in cm", 
                "safety_issue": "No"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01734486"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Height", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Bone maturation", 
                "safety_issue": "No"
            }
        ], 
        "source": "Novo Nordisk A/S", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novo Nordisk A/S", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 1996", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}